Respiratory infection caused by Mycoplasma hyopneumoniae has been a well-known feature of swine production for decades.
Its worldwide presence means that it has a substantial economic impact on most swine herds. Let’s take a look at the present and future perspectives from some of the main M.hyo specialists.
Videos & Publications about Mycoplasma hyopneumoniae
Control of Mycoplasma hyopneumoniae (M. hyopneumoniae) infections in pig herds can be accomplished by optimizing management and biosecurity practices and housing conditions.READ MORE
The intradermal needle-free piglets started feed intake 24h earlier than the intramuscular group. Low feed intake after weaning is a factor that negatively contributes to performance during the nursery phase.READ MORE
Intradermal needle-free vaccination against Mycoplasma hyopneumoniae and Porcine circovirus type 2-associated disease with Mhyosphere® PCV ID is safe to administer in weaned piglets and effective in preventing losses caused by these agents, improving weight performance, and reducing pneumonic lung lesions.READ MORE
The intradermal needle-free piglets started feed intake 24h earlier than the intramuscular group. Low feed intake after weaning is a factor that negatively contributes to performance during the nursery phase.READ MORE
The aim of this study was to compare lung lesions associated with Mhyo at slaughter when applying different Mhyo /PCV2 vaccines in pigs from Peru.READ MORE
The aim of the study was to assess the EN-like lesions from pigs coming from farms using different vaccination Mhyo vaccines in Spain.READ MORE
The aim of this trial is to compare lung lesions of two different Mhyo vaccination treatments in a Greek swine farm using AI Diagnos.READ MORE
The objective of the study was to compare lung lesions consistent with Mhyo at the slaughterhouse on several fattening farms in pigs with the same farrowing origin before and after using MHYOSPHERE® PCV ID.READ MORE
Artificial Intelligence Diagnos is a great breakthrough for the swine industry, because it is a new system to evaluate lesions caused by Enzootic Pneumonia and Atrophic Rhinitis with has very clear advantages.READ MORE
The aim of this publication was to show the effect of Mhyosphere® PCV ID vaccination in growth performance of vaccinated pigs.READ MORE
In the following video, we will see the efficacy evaluation of Mhyosphere® PCV ID under field conditions, in terms of lung lesion and reduction of PCV2 viremia.READ MORE
This publication explains the efficacy of Mhyosphere® PCV ID in terms of duration of immunity.READ MORE
In the following video, we will see the efficacy in terms of onset of immunity of Mhyosphere® PCV ID.READ MORE
This article reviews the different studies that have been conducted with the product to demonstrate its efficacy, both experimentally and in the field, and its beneficial effects on growth until the end of fattening period.READ MORE
Quim Segalés talks about the relation between the use of antibiotics and the efficacy of Mycoplasma hyopneumoniae vaccines.READ MORE